Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionHighPoint Advisor Group LLC
Latest Disclosed Ownership8,960 shares
Latest Disclosed Value $ 1,248,780
HighPoint Advisor Group LLC reports 0.07% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - HighPoint Advisor Group LLC filed a 13F-HR form disclosing ownership of 8,960 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,248,780 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 14, 2026 disclosing 8,966 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.07% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES Common Stock 375558103 8,960 -6 -0.07 1,249 13.45 0.0523
2026-05-14 2025-12-31 13F/A-2 GILEAD SCIENCES Common Stock 375558103 8,966 -11,568 -56.34 1,101 -51.73 0.0460
2026-02-04 2025-12-31 13F GILEAD SCIENCES Common Stock 375558103 23,106 2,572 2,836 0.1315
2025-11-05 2025-09-30 13F GILEAD SCIENCES Common Stock 375558103 20,534 1,004 5.14 2,279 5.27 0.1086
2025-08-07 2025-06-30 13F GILEAD SCIENCES Common Stock 375558103 19,530 463 2.43 2,165 9.01 0.1150
2025-05-05 2025-03-31 13F GILEAD SCIENCES Common Stock 375558103 19,067 105 0.55 1,987 9.00 0.1157
2025-02-12 2024-12-31 13F GILEAD SCIENCES Common Stock 375558103 18,962 -688 -3.50 1,823 3.64 0.0990
2024-11-04 2024-09-30 13F GILEAD SCIENCES Common Stock 375558103 19,650 587 3.08 1,759 175,700.00 0.1025
2024-08-08 2024-06-30 13F GILEAD SCIENCES Common Stock 375558103 19,063 -149 -0.78 1 0.00 0.0888
2024-05-14 2024-03-31 13F GILEAD SCIENCES Common Stock 375558103 19,212 1,394 7.82 1 -99.92 0.0917
2024-03-26 2023-12-31 13F GILEAD SCIENCES Common Stock 375558103 17,818 1,755 10.93 1,293 28.27 0.0926
2022-08-15 2022-06-30 13F GILEAD SCIENCES Common Stock 375558103 16,063 1,845 12.98 1,008 1.51 0.1102
2021-11-15 2021-09-30 13F GILEAD SCIENCES Common Stock 375558103 14,218 384 2.78 993 4.20 0.0973
2021-07-29 2021-06-30 13F GILEAD SCIENCES Common Stock 375558103 13,834 3,680 36.24 953 44.18 0.0960
2021-04-12 2021-03-31 13F GILEAD SCIENCES Common Stock 375558103 10,154 523 5.43 661 2.01 0.0765
2021-02-10 2020-12-31 13F GILEAD SCIENCES Common Stock 375558103 9,631 9,631 648 0.0789
2020-02-13 2019-12-31 13F GLACIER BANCORP INC Common Stock 375558103 0 -3,576 -100.00 0 -100.00
2019-11-12 2019-09-30 13F GLACIER BANCORP INC Common Stock 375558103 3,576 0 0.00 157 14.60 0.0347
2019-08-15 2019-06-30 13F/A-1 GLACIER BANCORP INC Common Stock 375558103 3,576 -8,087 -69.34 137 -82.30 0.0321
2019-08-15 2019-06-30 13F GILEAD SCIENCES Common Stock 375558103 11,663 0 774
2019-05-08 2019-03-31 13F GILEAD SCIENCES Common Stock 375558103 11,663 -348 -2.90 774 -3.37 0.1895
2019-02-20 2018-12-31 13F GILEAD SCIENCES Common Stock 375558103 12,011 -91 -0.75 801 -8.46 0.2122
2018-10-23 2018-09-30 13F GILEAD SCIENCES Common Stock 375558103 12,102 -211 -1.71 875 -6.02 0.2396
2018-08-20 2018-06-30 13F GILEAD SCIENCES Common Stock 375558103 12,313 66 0.54 931 5.68 0.2513
2018-06-11 2018-03-31 13F GILEAD SCIENCES Common Stock 375558103 12,247 -10,584 -46.36 881 -52.25 0.2419
2018-02-15 2017-12-31 13F GILEAD SCIENCES Common Stock 375558103 22,831 2,939 14.77 1,845 25.68 0.5285
2017-11-06 2017-09-30 13F GILEAD SCIENCES Common Stock 375558103 19,892 256 1.30 1,468 2.16 0.4553
2017-08-15 2017-06-30 13F GILEAD SCIENCES Common Stock 375558103 19,636 0 0.00 1,437 0.00 0.4624
2017-08-07 2017-03-31 13F GILEAD SCIENCES Common Stock 375558103 19,636 8,859 82.20 1,437 90.08 0.4624
2017-03-02 2016-12-31 13F GILEAD SCIENCES Common Stock 375558103 10,777 -297 -2.68 756 -9.68 0.2435
2016-11-21 2016-09-30 13F GILEAD SCIENCES Common Stock 375558103 11,074 51 0.46 837 -4.23 0.2947
2016-08-10 2016-06-30 13F GILEAD SCIENCES Common Stock 375558103 11,023 7,322 197.84 874 159.35 0.3065
2016-04-26 2016-03-31 13F GILEAD SCIENCES Common Stock 375558103 3,701 -8,692 -70.14 337 -70.39 0.2063
2016-01-26 2015-12-31 13F GILEAD SCIENCES COM 375558103 12,393 -4,728 -27.62 1,138 -32.30 0.7485
2015-10-29 2015-09-30 13F GILEAD SCIENCES COM 375558103 17,121 1,394 8.86 1,681 -8.69 1.8638
2015-07-09 2015-06-30 13F GILEAD SCIENCES COM 375558103 15,727 521 3.43 1,841 20.25 2.8434
2015-05-11 2015-03-31 13F GILEAD SCIENCES COM 375558103 15,206 4,244 38.72 1,531 38.55 2.3404
2015-02-24 2014-12-31 13F GILEAD SCIENCES COM 375558103 10,962 10,962 1,105 2.0349
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.